Kainic acid (KA), a potent central excitotoxin, may elicit neuronal death via generation of reactive oxygen species (ROS). The present study was undertaken to further characterize KA neurotoxicity and its relationship to ROS production and mitochondrial dysfunction. Exposure of rat cerebellar granule neurons at 14 days in vitro to 0.5 mM KA for 30 min resulted in the death of 53% of cells 24 h later. ROS production, evaluated by 2',7'-dichlorofluorescein diacetate, increased in KA-treated granule neurons. Resolution of mitochondrial oxidative phosphorylation enzymes by blue native polyacrylamide gel electrophoresis, followed by histochemical staining, showed that KA induced a strong decrease (-40%, P<0.01) in succinate dehydrogenase (SDH) activity of complex II. Western analysis revealed a marked reduction in quantity of the catalytic portion of complex II enzyme in KA-treated cells. No significant changes were observed in the activities of other mitochondrial complex enzymes. The actions of KA at the mitochondrial level, as well as on ROS generation and cell viability, were prevented by the KA receptor-selective antagonist 6,7-dinitroquinoxaline-2,3(1H, 4H)-dione. Pretreatment of granule neurons with melatonin, a direct scavenger of ROS, or with the reduced glutathione (GSH) delivery agent GSH ethyl ester, before KA challenge prevented both the decrease in cell viability and complex II damage. The last result supports a link between KA-induced mitochondrial oxidative enzyme dysfunction and ROS generation. Together the results suggest mitochondria to be a critical target in KA injury to neurons.
KA binds to and activates a subtype of ionotropic glutamate receptors (4) and, on the release of a potentially neurotoxic amount of glutamate (5) , induces Ca 2+ and Na + influx (6) . Considerable evidence supports a link between Ca 2+ influx and glutamate receptor-mediated neurodegeneration. Although mitochondria can buffer large Ca 2+ loads (7), they do so at the expense of producing injurious reactive oxygen species (ROS) (8) . As mitochondria lack catalase, intracellular reduced gluthatione (GSH) homeostasis is likely to play a crucial role in protecting this organelle from ROS-induced damage (9, 10) . Depletion of intracellular GSH stores by L-buthionine-(S,R)-sulfoximine (BSO), an inhibitor of GSH synthesis markedly decreased mitochondrial oxidative phosphorylation (OXPHOS) enzyme activity (11) . Inhibition of GSH synthesis favors ROS formation (11) , nitric oxide synthase activity (12) , excitotoxic vulnerability (13) , and larger infarct areas after ischemia (14) . GSH levels may also modulate injury caused by EAA receptor overstimulation. Markedly reduced brain GSH levels have been observed in rats systemically treated with KA (15) . In this model, sparing GSH by melatonin administration (16) markedly reduced KA neurotoxity (15, 17) . Moreover, KA toxicity to cultured cerebellar granule neurons was associated with a reduced GSH content (18) ; increasing cellular GSH levels with the membrane permeant GSH delivery agent, GSH ethyl ester prevented KA toxicity (18) .
Glutamate toxicity to cerebellar granule neurons appears to depend, at least in part, on release of cytocrome c from mitochondria and mitochondrial shuttle impairment (19) . This last observation supports a central role for mitochondria and mitochondrially generated ROS in EAA neurotoxicity. ROS produced as a consequence of KA receptor activation can destabilize membrane enzymes. Mitochondrial depolarization mediated by AMPA/KA receptor activation, observed in KA-treated spinal motor neurons, has been proposed as an important event underlying the neurodegenerative process in amyotrophic lateral sclerosis (20) . Mitochondrial dysfunction may occur in other neurodegenerative disorders where there is ROS production. For example, abnormalities in complex I (NADH: ubiquinone oxidoreductase) have been identified in platelets, brain, and muscle of Parkinson's disease patients (21, 22) , whereas complex IV (cytochrome c oxidase) deficiency has been reported in Alzheimer's disease brain (23) .
The present study was designed to explore further the molecular basis of KA neurotoxicity. In particular, the effects of KA on mitochondrial OXPHOS complexes of cultured rat cerebellar granule neurons were investigated, together with the neuroprotective potential of melatonin and GSH ethylester on KA-induced loss of mitochondrial OXPHOS activity.
MATERIALS AND METHODS

Cell culture
Cerebellar granule neuron cultures were prepared from 8-day-old rat pups (Sprague-Dawley, Harlan, S. Pietro al Natisone, Udine, Italy), as described previously (24) . Briefly, cerebella were dissected, freed of meninges, and minced with a razor blade. After trypsinization, tissue was triturated in the presence of DNase and trypsin inhibitor. Cells were then pelleted by centrifugation and resuspended in Eagle's basal medium containing 10% fetal calf serum, 2 mM L-glutamine, 50 µg/ml gentamicin, and 25 mM KCl. For viability assays, dissociated cells were seeded into 24-well plates, 6.5 × 10 5 cells per well in 0.7 ml medium. For assays on mitochondrial OXPHOS enzymes cells were plated in 35-mm dishes, at 3 × 10 6 cells per dish in 2.5 ml medium. All culture surfaces were coated with 10 µg/ml of poly-L-lysine (MW 35,000-70,000). After 24 h following cell plating, cytosine arabinofuranoside (10 µM) was added to inhibit growth of non-neuronal cells. Cultures were maintained at 37°C in a 95% air/5% CO 2 incubator, and were used at 14 days in vitro (DIV) without medium change. Fresh glucose (5 mM) was added to the cultures at DIV 7. Cultures generated by this method have been characterized and shown to contain > 95% granule neurons (24, 25) .
Neurotoxicity assays
KA was prepared in complete Locke's solution (154 mM NaCl, 5.6 mM KCl, 3.6 mM NaHCO 3 , 1.2 mM CaCl 2 , 5.6 mM glucose, 5 mM Hepes, pH 7.4). Cell monolayers were washed once with 0.5 ml Locke's solution and KA added. Unless specified otherwise, all incubations were performed at 22-24°C for 30 min. On conclusion of KA challenge, the cultures were washed twice with 0.5 ml of Locke's solution and returned to their culture-conditioned medium for further a 24 h. Neuron survival was quantified by a colorimetric method by using the metabolic dye 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) (26) . Culture medium was removed and replaced with 0.5 ml per well of Locke's solution containing 0.18 mg/ml MTT. After incubation for 30 min at 37°C, the MTT solution was removed and the reaction product was dissolved in 0.35 ml of dimethylsulfoxide. MTT is reduced to a blue formazan by mitochondrial dehydrogenases in living cells, but not by dying cells or their lytic debris (27) . Absorbance was read at 570 nm and 630 nm, and the results expressed as percentage of viability relative to the control culture (=100%).
Assay of ROS formation
ROS formation was determined fluorometrically by using 2',7'-dichlorofluorescein diacetate (DCF-DA) (28) . On entering cells, DCF-DA is de-esterified to the ionized free acid (DCFH), which then reacts with ROS to form the fluorescent 2',7'-dichlorofluorescein (DCF). In a typical experiment, cells were first washed with 1.5 ml of Locke's solution, and then were preincubated for 15 min (37°C) with DCF-DA (about 30 nmol/mg cell protein) in 2 ml of Locke's solution. DCF-DA was added from a stock solution in methanol; the quantity of methanol never exceeded 10 µl, and was always added to the blank. At the end of the incubation, the cells were washed with 2 ml of Locke's solution to remove extracellular DCF-DA. Cells were then treated with 0.5 mM KA for 30 min at 37°C, at which time the test solution was removed and 1.2 ml of 0.1 M KH 2 P0 4 /0.5% Triton X-100 (pH 7.0) added for 10 min. Cells were then scraped from the dish, and the extract was centrifuged (5 min, 12,000 rpm, Eppendorf microfuge). The supernatants were collected and the fluorescence was immediately read by using a Perkin-Elmer LS-3 spectrophotometer (excitation 488 nm, emission 525 nm; Foster City, CA). ROS formation was expressed as the amount of DCF formed, in reference to a DCF standard curve (3-100 nM). To correct for autofluorescence, controls were run in cells treated under the same experimental conditions but in KA-free medium. The basal DCF value was 4.32 ± 0.43 pmol/mg protein/min.
Extraction of granule neuron mitochondrial OXPHOS enzymes
Granule neurons (6 × 10 6 /dish) were scraped into 1 ml physiological salt solution (PBS) and the cell suspension was centrifuged at 20,000 x g for 10 min. The cell pellet was resuspended in 100 µl of PBS and permeabilized by addition of 100 µl of 8 mg/ml digitonin, freshly prepared (29) . Protein content was determined according to Lowry et al. (30) . After 15 min at 4°C the cell suspension was diluted with 1 ml cold PBS and centrifuged for 30 min at 100,000 x g. The pellet was suspended in 100 µl of 1.5 M 6-aminocaproic acid, 50 mM Bis-Tris/HCl pH 7.0 (4°C) containing protease inhibitors (20 µM PMSF, 20 µM TPCK, 1 µg/ml pepstatin, and 1 µg/ml leupeptin). Mitochondrial OXPHOS enzymes were solubilized by adding 20 µl of 10% freshly prepared dodecylmaltoside (29) . After centrifugation at 100,000 x g for 25 min, the supernatants were collected and protein was measured (31) . The extracts were used immediately for blue native polyacrylamide gel electrophoresis (BN-PAGE) or stored at -80°C for several months.
Polyacrylamide gel electrophoresis
BN-PAGE was performed by using a minigel apparatus (BioRad miniprotean, 1 × 70 × 82 mm) and a 5%-11% polyacrylamide gradient. Lanes were loaded with 14-20 µl of sample (approximately 20 µg protein) plus 1 µl 5% Serva Blue G in 1 M aminohexanoic acid. BN-PAGE was performed as described (32) , with the blue cathode buffer replaced by an uncolored buffer immediately after samples entered the resolving gel. Gels were fixed and stained with Coomassie blue G. Bands were scanned by using a HP3 Scanjet and quantified by densitometric analysis by using Sigma Plot (Jandel, Sigma, St. Louis, MO). Band areas were expressed as absolute values (arbitrary units).
Histochemical evaluation of BN-PAGE gels
BN-PAGE gels were subjected to enzymatic colorimetric staining without delay (33) . Complex I (NADH) activity was determined by incubating gel slices with 2 mM Tris-HCl pH 7.4, 0.1 mg/ml NADH, and 0.25 mg/ml nitroblue tetrazolium chloride (NTB) at room temperature. Complex II (succinate dehydrogenase; SDH) activity was evaluated by incubating gel slices with 4.5 mM EDTA, 10 mM KCN, 0.2 mM phenazine metasulphate, 84 mM succinic acid, and 50 mM NTB in 1.5 mM phosphate buffer, pH 7.4 (22-24 °C). Complex IV (cytochrome oxidase; COX) activity was estimated by incubating gels with 5 mg of 3, 3'-diaminobenzidine tetrahydrochloride (DAB) in 9 ml phosphate buffer (0.05 M, pH 7.4), 1 ml catalase (20 µg/ml), 10 mg cytochrome c, and 750 mg sucrose. Granule neuron extracts produced a maximum color yield after 4 h. Gels were fixed in 50% methanol/10% acetic acid for 15 min and preserved in 10% acetic acid. The violet-colored Complex I and Complex II bands and the red-stained Complex IV bands were analyzed by scanning the wet gel with a HP3 Scanjet; integration of areas corresponding to mitochondrial complexes was performed by using Sigma Plot. Band areas were expressed in absolute values (arbitrary units).
Western blot analysis
OXPHOS complexes extracted from purified mitochondria or cerebellar granule neurons were resolved by BN-PAGE as described above, and blotted onto nitrocellulose membranes (34) by using a transblot SD semidry transfer cell (BioRad). Complete and reproducible transfer of native complexes was obtained in 2 h at 20 V. The nitrocellulose membrane was cut into two strips corresponding to the resolved mitochondrial complexes; that is, complex V and complex II. Each strip was probed with specific polyclonal antibodies. Rabbit anti-complex V IgG was prepared by using the F1 catalytic portion of ATP synthase as immunogen, while rabbit anticomplex II subunit (70 and 27 kDa IgGs) was a kind gift of Prof. Turnbull, University of Newcastle (U.K.). Alkaline phosphatase-conjugated species anti-rabbit IgG (Sigma) was used as secondary antibody. Immunoreactive bands were visualized by incubating the membrane in 0.1 M Tris-HCl, 0.1 M NaCl,, 6 mM MgCl 2 (pH 9.5) and 7 µg bromochloroindolyl phosphate. Nitroblue tetrazolium (3.5 µg) was then added and the color was allowed to develop for 10 min. The membrane was scanned and quantified as for BN-PAGE gels.
Assay of GSH cellular content
Cellular GSH levels were measured enzymatically by using a modification of the procedure of Tietze (35), as described by Floreani et al. (36) , based on the determination of a chromophoric product, 2-nitro-5-thiobenzoic acid, resulting from the reaction of 5,5'-dithiobis-(2-nitrobenzoic acid) with GSH. In this reaction, GSH is oxidized to GSSG, which is then reconverted to GSH in the presence of GSH reductase and NADPH. The rate of 2-nitro-5-thiobenzoic acid is followed at 412 nm. Immediately following the 30 min KA exposure, cell monolayers were washed once with Locke's solution, and 2 ml of 6% metaphosphoric acid was added. After 10 min on ice, the acid extract was collected, centrifuged, and processed for GSH determination. To 0.1 ml of supernatant, 0.75 ml 0.1 M potassium phosphate/5 mM EDTA buffer (pH 7.4), 0.05 ml of 10 mM 5,5'-dithiobis-(2-nitrobenzoic acid) (prepared in 0.1 M phosphate buffer) and 0.08 ml of 5 mM NADPH were added. After a 3-min equilibration period at 25°C, the reaction was started by the addition of 2U glutathione-reductase (type III from baker's yeast, Sigma, diluted in 0.1 M phosphate/EDTA buffer). Product formation was recorded continously at 412 nm (25°C) with a Shimadzu UV-160 recording spectrophotometer. The total amount of GSH in the samples was determined from a standard curve obtained by plotting known amounts (0.05-0.4 µg/ml) of GSH vs. the rate of change of absorbance at 412 nm. GSH standards were prepared daily in 6% metaphosphoric acid and diluted in phosphate/EDTA buffer (pH 7.4). GSSG cellular content was typically less than 2% of GSH level and was not considered.
Reagents
All reagents were of the highest quality available. Serva Blue G (Coomassie blue) was obtained from Serva (Heidelberg, Germany); dodecyl maltoside from Boehringer (Mannheim, Germany); digitonin from Merck (Darinstad, Germany); 6 aminocaproic acid from Fluka (Milan, Italy); acrylamide and bisacrylamide from BioRad (Milan, Italy); and melatonin, KA, DCF, and all salts, buffers, and dyes from Sigma-Aldrich (Milan, Italy). DCF-DA was obtained from Molecular Probes, Inc. (Eugene, OR, USA). 6,7-Dinitroquinoxaline-2,3-dione (DNQX) was from Tocris Cookson Ltd. (Bristol, U.K.).
Statistical analysis
All data were analyzed by ANOVA and Bonferroni test. Significance was taken as P<0.05.
RESULTS
Effect of KA on cerebellar granule neuron survival
In preliminary experiments mature (14 DIV) cerebellar granule neurons were treated with a range (0.05-1 mM) of KA concentrations for 30 min. Cells were then washed free of KA and returned to their cultured-conditioned medium for a further 24 h before assessment of survival. KA concentration-dependently decreased cell viability; at the highest dose (1 mM) KA reduced neuron viability to 46.0 ± 4.0 % of control (n=6). This cell death did not differ significantly from that obtained with 0.5 mM KA (53.6 ± 4.0%). The latter KA dose was used in all subsequent experiments. Significant injury by KA required a 30-min exposure to the excitotoxin and reached a maximum between 30 and 60 min of KA challenge. A 30-min incubation time for KA was chosen for the remainder of the study. Similar levels of cell loss were observed when using trypan blue exclusion as an index of viability (data not shown). Cell death was also evident morphologically, with degeneration and fragmentation of neuronal somata and disintegration of the accompanying neurite network.
Effect of KA on mitochondrial OXPHOS enzymes
Mitochondrial OXPHOS enzymes extracted from control and KA-treated (0.5 mM) cells were resolved by BN-PAGE, followed by Coomassie blue and histochemical staining. A typical gel is shown in Figure. 1. Quantitative densitometric analysis of the BN-PAGE-resolved complexes revealed a dramatic decrease in the SDH activity of complex II. Figure 2 summarizes the results for control and KA-treated granule neurons. Protein content is expressed in arbitrary units for complex V and complex III Coomassie blue stained areas, whereas OXPHOS enzyme activities are given in arbitrary units for band areas derived from gels with histochemical staining. The latter analysis confirmed KA treatment to cause a dramatic (-40%) and significant (P=0.0081) decrease in neuronal mitochondrial complex II activity. Smaller, nonsignificant decreases were observed for the other enzymatic activities on the gel.
To gain further insight into the molecular target of KA action, the effect of direct KA (5 and 500 µM) application on isolated brain mitochondria was examined. Under these conditions no statistically significant alterations in OXPHOS enzyme activities were seen (n=5, data not shown). A link between KA receptor engagement and mitochondrial toxicity was suggested, however, by the fact that pretreatment of granule neurons with the KA receptor antagonist DNQX (37) completely prevented the decrease in complex II (SDH) activity (Fig. 3) . Western blot analysis of mitochondrial complex II (Fig. 4) revealed that the KA-induced decrease in SDH activity was accompanied by a marked reduction in the catalytic portion of the enzyme. This latter loss was prevented by DNQX.
KA stimulates ROS production in cerebellar granule neurons
KA treatment (30 min) of granule neurons increased ROS production as assessed by DCF ( Table  1) . Stimulation of ROS production upon excitotoxin challenge clearly was due to activation of KA receptors, as it was significantly diminished by DNQX. Not unexpectedly, the KA-induced decrease in cell viability was completely prevented by DNQX (data not shown).
Antioxidants prevent KA-induced GSH decrease and mitochondrial injury
The data strongly propose a direct link between KA-induced ROS production and mitochondrial compromise. To provide further support for this view, KA (0.5 mM)-challenged granule neurons were either treated concurrently with the well-known antioxidant melatonin (0.5 mM) (38) or pretreated (30 min before KA addition) with the GSH delivery agent GSH ethyl ester (5 mM). The latter significantly increased intracellular GSH (18) and counteracted the KA-induced losses in cell viability (data not shown) and SDH activity (Table 2) , as well as SDH degradation (data not shown). Mitochondrial toxicity in KA-treated granule neurons was also prevented by melatonin. The pineal secretory product significantly (P<0.001) ameliorated KA-induced decrease in cell viability, from 52 ± 4.5% to 93 ± 2% in KA-and KA + melatonin-treated cells, respectively. Moreover, melatonin completely prevented the decrease in granule neuron GSH content caused by KA (Fig. 5 ) and, as is clearly shown in Table 2 , prevented the loss in mitochondrial complex II (SDH) enzymatic activity.
DISCUSSION
A principal finding of the present study is that exposure of cerebellar granule neurons to KA resulted in a concommitant increase in ROS production and an impairment of mitochondrial OXPHOS enzyme function. In particular, the catalytic portion of mitochondrial complex II was compromised with consequent loss of SDH activity. The selective KA/AMPA receptor antagonist DNQX prevented both KA-induced ROS overproduction and complex II damage.
Free radical generation appears to be a central feature in the mechanism of KA-elicited neuronal death. Free radical formation, together with increased lipid peroxidation has been detected in brain 1 h after KA administration (39) . Ionotropic-but not metabotropic glutamate receptor agonists-reportedly increase the rate of ROS formation in a synaptoneurosomal fraction from rat cerebral cortex (17) . In striatal (40) , cortical (20) , and cerebellar granule neurons (18) , KA treatment increased ROS production, which could be prevented by lipophilic antioxidants (41) . ROS overproduction in neurons parallels a substained increase in intracellular Ca 2+ with consequent mitochondrial Ca 2+ accumulation (42) . Although mitochondria can buffer large amounts of Ca 2+ in response to receptor activation (42), they do so at the expense of triggering ROS production. This sequence of events has been described in GABAergic cortical neurons (43) and spinal motor neurons (20) . KA receptor activation triggers Ca 2+ entry (44) and generation of ROS (18) in cultured cerebellar granule neurons, as well. The present findings do not allow one to identify the cellular compartment(s) in which ROS production occurs, and an extra-mitochondrial site cannot be excluded. In granule neurons inhibition of xanthine oxidase, a cytosolic source of superoxide anion, prevents KA toxicity (45) .
KA triggered a series of events, which culminated in impaired mitochondrial function of cerebellar granule neurons. Mitochondrial damage was manifested as a specific and marked decrease in the activity (SDH) of complex II. Western blot analysis revealed that the catalytic portion of this enzyme was lost in mitochondrial fractions extracted from KA-treated neurons. Such selective enzyme inactivation is not easily explained. Complex II (succinate-ubiquinoneoxidoreductase) is critical for both the tricarboxylic acid cycle (Krebs cycle) and the mitochondrial respiratory chain (46) and is the simplest enzyme complex of the electron transport respiratory chain. Two of the four subunits composing complex II constitute the catalytic portion (succinate-dehydrogenase): the 70 kDa flavoprotein (Fp) and the 27 kDa ironprotein (three non-heme iron-sulfur centers); these project into the matrix (47) . Under the present experimental conditions detergent extraction required for BN-PAGE (33) could lead to loss of the catalytic portion of complex II, made labile by ROS interaction or by Ca 2+ -activated proteases. In this respect, KA effects resemble those of 3-nitropropionic acid (48) and malonate (49) . 3-Nitropropionic acid, an irreversible inhibitor of complex II, induces neuronal apoptosis in vivo and in vitro by a mechanism involving oxidative stress, Ca 2+ elevation, nitric oxide synthase activation, and production of reactive nitrogen species (RNS) (50) . Malonate, although not an irreversible inhibitor of SDH, produces analogous effects, including intracellular Ca 2+ elevation, ROS and RNS production, and apoptosis (49, 51) . Enhanced RNS generation by KA could conceivably occur also in granule neurons, due to raised Ca 2+ levels and activation of nitric oxide synthase (12, 26) . Experiments are in progress to test this hypothesis.
The tight relationship between KA toxicity and ROS production emphasizes the importance of cellular antioxidant defenses in modulating KA neurotoxicity. The cellular level of GSH, a key antioxidant defense molecule, is a key player in determining the sensitivity of cerebellar granule neurons to KA toxicity (18) . The results described here clearly demonstrate that increasing cellular GSH levels can protect neurons from mitochondrial damage caused by KA exposure and a sustained ROS overproduction. Both the membrane-permeant GSH delivery agent GSH ethyl ester (18) and melatonin, a free radical scavenger (38) capable of preserving GSH homeostasis via a sparing action on GSH reductase (16), each increased GSH concentrations (present results; 18) and preserved SDH activity. Several recent reports attest to melatonin action at the mitochondrial level, whereby the pineal product prevented ruthenium red-induced mitochondrial damage via increased activity of respiratory chain complexes I and IV (26) and afforted protection against 1-methyl-4-phenylpyridinium-induced inhibition of complex I (53) . Taken together, the data further strengthen the notion that molecules, which maintain glutathione balance in the brain, represent putative neuroprotective agents for the treatment of central nervous system pathologies involving excitotoxicity or where oxidative damage may contribute to mitochondrial dysfuntion, for example Parkinson's disease, Huntington's disease, and amyotrophic lateral sclerosis (5, 54) . were incubated with 0.5 mM melatonin and 0.5 mM KA for 30 min, after which time cells were processed for measurement of intracellular GSH content. Values are means ± SE (six experiments). *P < 0.01 vs. KA + melatonin cultures.
